Join
Live feed
·
INSIDERFilingvia Quantisnow
Acasti Pharma Inc. logo

Kavuru Vimal bought $1,249,934 worth of shares (676,371 units at $1.85) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACST (Acasti Pharma Inc.) and more on Quantisnow.